1Chalmers J,et al.WHO-ISH Hypertension Guidelines Committee.1999World Health Organization-International Society of Hypertension GuidelinesfortheManagementof Hypertension[].Journal of Hypertension.1999
2Staessen JA,Fagard RH,Lijnen PJ,et al.Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies[].The American Journal of Cardiology.1991
3Devereux RB.Detection of left ventricular hypertrophy by Mmode echocardiography, anatomic validation, standardization, and comparison to other methods[].Journal of Hypertension.1987
4Teichholz LE,Kreulen FT,Herman FMV,et al.Problems in echocardio-graphy volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy[].The American Journal of Cardiology.1996
5Mackay JH,Arcuri KE,Goldberg AI,et al.Losartan and low dose hydrochlorothiazide in patients with essential hypertension[].Archives of Internal Medicine.1996
6Cottone S,Vadala A,Vella MC,et al.Changes of plasma endothelin and growth factor levels, and of left ventricular mass, after chronic AT1-receptor blockade in human hypertension[].American Journal of Hypertension.1998
7Gottdiener JS,Reda DJ,Massie BM,et al.Effect of single drug therapy on reduction of left ventricularmass in m ild to moderate hypertension: comparison of six antihypertensive agents[].Circulation.1997
4Guidelines sub - committee. Guideline for europear society of management of hypertension [ J ]. J Hypertension, 2003, 21 : 1011.
5J Coel M, Neutel MD, Dvid HG, et al. Evaluation of angiotensin Ⅱ receptor blockers for 24- Hour blood pressure control: meta - analysis of a clinical database[J]. J Clin Hypertens, 2003, 5(1) :58 - 63.
6Sica DA, School werth AC. Uric acid and losartan[J]. Curr Opin Neprol Hypertens, 2002, 11 (5) : 475 - 482.
7Nguyen QT, Colombo F, Clement R, et al. AT1 receptor antagonist therapy p referentially ameliorated right ventricular funcion and phenotype during the early phase of remodeling post-MI[J]. Br J Phannacol, 2003, 138(8): 1485- 1494.
8Wong M, Staszewsky L, Latini R, et al. Valsartan benefits left ventrivular structure and function in heart failure: Val- HeFt echocardiographic study[J]. J Am Coil Carclio, 2002, 40: 970.
9Nakao N, Yoshimura A, Morita H, et al. Combination treatment of angiotensin - Ⅱ receptor blocker and angiotensin- converting- enzyme inhibitor in non - diabetic renal disease (COOPERATE): a randomized controlled trial[J]. Lacet, 2003, 361:117-124.
10Yamaha A,Arita M,Fumta M,et al.The angiotensin receptor Mocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control[J].Diabetes Res Clin Pract,2008,82(7):127-131.
